focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Close of Offers

3 Apr 2024 07:57

RNS Number : 1255J
British Smaller Companies VCT2 Plc
03 April 2024
 

British Smaller Companies VCT2 plc (the "Company")

Issue of Equity and Close of Offers

On 20 September 2023 British Smaller Companies VCT2 plc and British Smaller Companies VCT plc (together the "Companies") launched offers for subscription (the "Offers") seeking to initially raise £65 million in aggregate for the 2023/24 tax year. On 13 December 2023, the Companies confirmed that the over-allotment facility of £25 million included in the Offers will be used in full. This increases the maximum amount which can be raised under the Offers to £90 million in aggregate.

The first allotment allotting shares relating to gross proceeds of £30.0 million under the Offers took place on 30 January 2024.

The Company announces that today, 3 April 2024, it has made the second and final issue of ordinary shares pursuant to the Offers by allotting 37,666,087 ordinary shares of 10 pence each, raising gross proceeds of £23.1 million. This allotment was made in respect of the tax year 2023/2024. In accordance with the pricing formula set out in the Prospectus, the new ordinary shares were allotted at offer prices of between 59.96 pence and 63.95 pence per share depending on the adviser charge (if applicable) and the number of shares issued pertaining to each application. Applicants received additional New Shares equivalent to receiving a 3.70 per cent per annum rate of return on funds awaiting allotment, calculated by reference to the number of days between the acceptance of an Application (including full receipt of cleared funds) and the date of allotment.

The net asset value ("NAV") used for the calculation of the issue price on 3 April 2024 is the last reported NAV of 59.3 pence per ordinary share, being the audited NAV as at 31 December 2023.

Together, the Companies have in total on 30 January 2024 and 3 April 2024 allotted shares relating to gross proceeds of £90.0 million under the Offers, of which £34.5 million has been raised by the Company and £55.5 million has been raised by British Smaller Companies VCT plc.

In this allotment Barbara Anderson, non-executive Director of the Company, has been allotted 79,558 ordinary shares of 10 pence in the Company, bringing her aggregate total holding to 619,754 ordinary shares.

In this allotment Peter Waller, non-executive Director of the Company, has been allotted 9,836 ordinary shares of 10 pence in the Company, bringing his aggregate total holding to 73,647 ordinary shares.

In this allotment the employees and members of the Manager, YFM Private Equity Limited, have been allotted 41,877 ordinary shares of 10 pence each in the Company, bringing their aggregate total holding to 776,515 ordinary shares.

Applications are now being made by the Company for the ordinary shares which were allotted on 3 April 2024 to be admitted to the premium segment of the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities. Dealings are expected to commence on or around 5 April 2024.

Following the allotment of 37,666,087 ordinary shares, the Company's issued share capital consists of 284,639,146 ordinary shares with voting rights ("Voting Capital") and 22,702,746 shares held in treasury.

The above statement of Voting Capital may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

3 April 2024

For further information, please contact:

Dan Perkins YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFIFERSRIVIIS
Date   Source Headline
10th Jun 20211:25 pmRNSResult of AGM
26th Mar 20218:35 amRNSTransaction in Own Shares
12th Mar 20212:44 pmRNSAnnual Financial Report
11th Mar 20212:52 pmRNSDirector/PDMR Shareholding
11th Mar 20212:51 pmRNSIssue of Equity and Close of Offer
5th Mar 20219:14 amRNSPayment of dividend and issue of equity
3rd Mar 20219:55 amRNSClose of Offer to Further Applications
22nd Feb 20214:15 pmRNSUpdate on Offer
2nd Feb 202110:00 amRNSOffers for Subscription
2nd Feb 202110:00 amRNSOffers for Subscription
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSNet Asset Value and Proposed Fundraising
27th Jan 20218:42 amRNSDividend Declaration
15th Dec 202011:42 amRNSTransaction in Own Shares
11th Dec 20209:30 amRNSProposed Fundraising
11th Dec 20209:30 amRNSProposed Fundraising
25th Nov 20204:00 pmRNS3rd Quarter Results
28th Sep 20207:15 amRNSTransaction in Own Shares
28th Sep 20207:14 amRNSDirectorate Change
21st Sep 202010:03 amRNSPayment of Dividend and Issue of Equity
12th Aug 20202:02 pmRNSReplacement Half-year Report to 30 June 2020
12th Aug 202010:15 amRNSHalf-year Report to 30 June 2020
29th Jun 202011:53 amRNSTransaction in Own Shares
24th Jun 202011:15 amRNSInterim Management Statement
16th Jun 20203:52 pmRNSResult of Annual General Meeting
28th May 20208:25 amRNSAnnual General Meeting
12th May 202012:49 pmRNSPayment of Dividend (amended)
12th May 20209:00 amRNSPayment of Dividend
26th Mar 20204:30 pmRNSNet Asset Value
20th Mar 20204:00 pmRNSTransaction in Own Shares
20th Mar 20204:00 pmRNSTemporary suspension of DRIS & Buyback policy
20th Mar 20209:41 amRNSAnnual Financial Report
19th Dec 201910:17 amRNSTransaction in Own Shares
21st Nov 20191:00 pmRNSInterim Management Statement
27th Sep 20199:30 amRNSPurchase of Own Securities and Net Asset Value
23rd Sep 201910:10 amRNSPayment of Dividend and Issue of Equity
14th Aug 20199:14 amRNSHalf-year Report
10th May 20199:43 amRNSPayment of Final Dividend and Issue of Equity
7th May 20192:18 pmRNSResult of AGM and Change of Chairman
7th May 20199:53 amRNSInterim Management Statement
4th Apr 201912:13 pmRNSDirector/PDMR Shareholding
4th Apr 201912:13 pmRNSDirector/PDMR Shareholding
4th Apr 201912:11 pmRNSDirector/PDMR Shareholding
4th Apr 201912:10 pmRNSDirector/PDMR Shareholding
1st Apr 20193:51 pmRNSIssue of Equity
1st Apr 20193:44 pmRNSIssue of Equity and Close of Offers
27th Mar 201910:19 amRNSTransaction in Own Shares and Net Asset Value
26th Mar 20194:29 pmRNSPublication of Supplementary Prospectus
26th Mar 20194:27 pmRNSPublication of Supplementary Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.